Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.

about

Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review.Immune Checkpoint Targets for Host-Directed Therapy to Prevent and Treat Leishmaniasis.Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.

P2860

Q38962452-35FDDCAF-7310-4E85-9B2A-81EFD1992D6B Q46080853-5E53363C-A202-48A6-BD79-3C80ECBE49E2 Q50130388-7C803A43-3630-413F-88F4-E6321E198942

P2860

Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.

Item

http://www.wikidata.org/entity/Q40939652

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Potential Use of Interleukin-1 ...... Human Cutaneous Leishmaniasis.

@en

type

Item

label

Potential Use of Interleukin-1 ...... Human Cutaneous Leishmaniasis.

@en

prefLabel

Potential Use of Interleukin-1 ...... Human Cutaneous Leishmaniasis.

@en

P1476

Potential Use of Interleukin-1 ...... Human Cutaneous Leishmaniasis.

@en

P2093

Alain Dessein

http://www.w3.org/2001/XMLSchema#string

Dalmo Correia

http://www.w3.org/2001/XMLSchema#string

Helia Dessein

http://www.w3.org/2001/XMLSchema#string

Laurent Argiro

http://www.w3.org/2001/XMLSchema#string

Marcos Vinícius da Silva

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis

The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis

Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects.

Up-regulation of Th1-type responses in mucosal leishmaniasis patients

IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis.

Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis

CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis

Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis.

Strategies for use of IL-10 or its antagonists in human disease.

P304

152741

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/152741

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

V Rodrigues Júnior

Lúcio R Castellano

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282400337

http://www.w3.org/2001/XMLSchema#string

P698

26495321

http://www.w3.org/2001/XMLSchema#string

P932

4606169

http://www.w3.org/2001/XMLSchema#string

Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.

about

P2860

P2860

Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932